AnalystsCorinne JohnsonCorinne Johnson's Stock Forecasts
AnalystsCorinne Johnson
Sectors:
Analyst Ranking
Top 29%
#1504 out of 5177 analysts
Average Return
+19.94%
Win Rate
43%6 out of 14
Risk vs Reward
Poor
Good
Corinne Johnson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avidity Biosciences IncRNA | +130.41% | $31.47 | $72.51 | 2025-07-09 - 2026-01-16 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +108.96% | $9.82 | $20.52 | 2025-07-09 - 2026-01-16 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +93.50% | $7.39 | $14.30 | 2025-07-09 - 2026-01-16 | Strong Buy |
Arrivent Biopharma IncAVBP | +31.41% | $20.63 | $27.11 | 2024-02-19 - 2025-02-19 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +20.42% | $17.04 | $20.52 | 2025-09-04 - 2026-01-16 | Strong Buy |
Corinne Johnson Analyst Color
Get additional color on Corinne Johnson's coverage of popular stocks
Corinne Johnson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tg Therapeutics IncTGTX | 1 | Hold | $39.00 | +27.58% | Maintains | 2 days ago |
Immunovant IncIMVT | 2 | Hold | $28.00 | +6.59% | Maintains | a month ago |
Mbx Biosciences IncMBX | 1 | Strong Sell | $18.00 | -55.59% | Initiates Coverage On | a month ago |
Amylyx Pharmaceuticals IncAMLX | 2 | Strong Buy | $20.00 | +39.86% | Maintains | 4 months ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $24.00 | +16.96% | Maintains | 4 months ago |
Avidity Biosciences IncRNA | 2 | Strong Buy | $55.00 | -24.15% | Reinstates | 6 months ago |
Arrivent Biopharma IncAVBP | 3 | Strong Buy | $33.00 | +58.20% | Reinstates | 6 months ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $182.00 | +37.47% | Initiates Coverage On | 6 months ago |
Cg Oncology IncCGON | 3 | Strong Buy | $50.00 | N/A | Upgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.